Abu Dhabi: Hospital to study eye disease detected among teens that can lead to blindness

Cleveland Clinic Abu Dhabi’s Eye Institute and Research Department will be conducting a research study to measure the prevalence of keratoconus in the UAE to help understand and treat the disease more effectively.

The hospital, a Mubadala Health partner, is raising awareness around keratoconus – a progressive and degenerative corneal eye disease that, if left untreated, can result in blindness. In the UAE, rates of keratoconus are higher than in other parts of the world.

Keratoconus is usually detected in the teenage years or 20s but can also start in childhood. Its exact cause is unknown, and there are no eye diseases or injuries that explain why the cornea’s structure weakens and changes shape. This makes the role of preventative screening and timely detection even more critical so accurate treatment is provided to manage the extent of distortion.

Dr David Gritz, staff physician, cornea and refractive disorders, Eye Institute, CCAD, noted the hospital seeks to promote advanced research to address complex medical needs of the community.

“Our aim is to study the prevalence and incidence of the disease in the local population, which will enable us in our efforts with the governing authorities to develop a comprehensive national screening programme, and further serve our community.”

Keratoconus occurs when the cornea, the transparent outer lens of the eye, which normally has a dome shape with a ball-like appearance, is unable to maintain its round shape and extends outward in the form of a cone. While the exact cause is largely unknown, some research studies suggest that keratoconus runs in families and occurs more often in people with specific medical conditions.

What are the symptoms of keratoconus?

• UAE: 2,000 steps a day can lower your risk of premature death